Obesity Drugs and Therapies: Technologies and Global Markets
The global market for obesity treatments should reach more than $7.8 billion by 2021 from over $4.3 billion in 2016 increasing at a compound annual growth rate (CAGR) of 12.7% from 2016 to 2021.
The bariatric surgeries market should reach over $4.3 billion by 2021 from almost $3.4 billion in 2016, at a CAGR of 5.0% from 2016 to 2021.
The FDA-approved drugs market should reach $2.9 billion by 2021 from $455.0 million in 2016, a CAGR of 44.9% from 2016 to 2021.
